FTSE 100 zooms over 2% to a 9-month high on Brexit deal optimism

December 29, 2020 03:35 PM GMT | By Hina Chowdhary
 FTSE 100 zooms over 2% to a 9-month high on Brexit deal optimism

UK stock markets cheered the post-Brexit trade arrangement between Britain and the European Union on Tuesday, 29 December, with the headline FTSE 100 rising more than 2 per cent to a nine-month high. Market participants have seemingly rejoiced at the outcome of the long-awaited trade deal between the UK and the partner nations of the European Union that would be followed after the termination of Brexit transition deadline.

Markets celebrate Brexit deal cheer

The currency market also celebrated the Brexit deal optimism with the pound sterling regaining strength against the US counterpart. As per the latest foreign exchange data available, a unit of Great Britain pound (GBP) vs United States dollar (USD) pair was trading at 1.3504, up 0.41 per cent the previous close. In the intraday trade, a unit of pound sterling equalled 1.3523 USD.

A market-wide value buying has been observed in the domestic equities on Tuesday with all the major stock indices including FTSE 100, FTSE 250, FTSE 350 and FTSE All-Share gaining more than 2 per cent during the day so far. According to the data available with the London Stock Exchange, the benchmark FTSE 100 amassed a gain of 174.49 points or 2.68 per cent to hit a nine-month peak of 6,676.60 on Tuesday from the previous closing of 6,502.11 as on 24 December.

FTSE 100 (29 December)

(Source: Refinitiv, Thomson Reuters)

However, the index pared partial gains in the late afternoon trades. At around 1509 GMT, FTSE 100 was trading at 6,623.18, up 121.07 points or 1.86 per cent.

AstraZeneca jumps on hopes of vaccine approval

A positive Wall Street opening also favoured the rally on the London Stock Exchange with the shares of AstraZeneca Plc (LON: AZN) providing substantial support to the headline stock index. The stock of AstraZeneca surged nearly 5 per cent in the intraday trade on the hopes of an emergency usage approval for its vaccine. AstraZeneca share price jumped as much as 4.92 per cent to a day’s high of GBX 7,578.24 from the previous closing price of GBX 7,223.

Commodity check

In the commodities market, an ounce of spot gold traded at $1,877.51, up 0.24 per cent as the investors continued to incline towards the yellow metal among the safe haven assets with the USD losing its dominance against a basket of currencies. The energy market extended the gains on Tuesday with the Brent crude oil trading at $51.34 per barrel, up 0.86 per cent, while the WTI crude oil hovered 0.99 per cent higher at $48.09 a barrel.

The crypto market continued in the negative territory with bitcoin trading nearly 2 per cent lower below the mark of $27,000, Binance data showed. Bitcoin has been oscillating near its all-time high lately after surpassing the psychological level of $28,000 continuing the recent rally.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next